US 11389473
Magnesium-containing oxytocin formulations and methods of use
granted A61KA61K33/06A61K38/095
Quick answer
US patent 11389473 (Magnesium-containing oxytocin formulations and methods of use) held by TONIX PHARMACEUTICALS HOLDING CORP expires Mon Jul 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TONIX PHARMACEUTICALS HOLDING CORP
- Grant date
- Tue Jul 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61K, A61K33/06, A61K38/095, A61K45/06, A61K47/02